Clinical Science of Type 2 Diabetes Mellitus

Publisher： Elsevier

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.9, Iss.1, 1998-01, pp. : 43-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Current Diabetes Reviews, Vol. 13, Iss. 4, 2017-07 ,pp. : 405-423

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of lixisenatide in the treatment of Type 2 diabetes mellitus: a review of Phase III clinical data

By Raccah Denis

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 2, 2013-03 ,pp. : 105-121

Informa Healthcare

Access to resources Recommend Favorite

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

By Forst Thomas Pfützner Andreas

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

By Costi María Dilla Tatiana Reviriego Jesús Castell Conxa Goday Albert

Acta Diabetologica, Vol. 47, Iss. 1, 2010-12 ,pp. : 169-175

Springer Publishing Company

Access to resources Recommend Favorite

Commentary: Diagnostic Validity and Clinical Utility of HbA1c Tests for Type 2 Diabetes Mellitus

Current Diabetes Reviews, Vol. 14, Iss. 2, 2018-03 ,pp. : 196-199

Bentham Science Publishers

Access to resources Recommend Favorite